Array BioPharma (NASDAQ:ARRY)

4 Price Momentum Stocks Hedge Funds Love Could Be Big Summer Winners

Posted: June 12, 2019 at 7:35 am

We have noted that hedge fund performance over the past couple of years, especially by some of the bigger funds, has trailed the overall market performance. Part of the problem ...
Read Full Story »

Why 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates

Posted: January 31, 2019 at 7:40 am

If most investors thought their portfolios took a beating during the final quarter of 2018, it was a good thing they were not all-in on the biotechnology segment. The VanEck ...
Read Full Story »

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

Posted: December 31, 2017 at 10:15 am

After a horrible 2015 and 2016, the biotechnology industry finally came back to life in 2017, shrugging off many of the issues that have clouded the waters, especially during the ...
Read Full Story »

4 Red-Hot Tech and Biotech Stocks to Buy With Up to 100% Upside Potential

Posted: December 27, 2017 at 8:20 am

For investors who have watched the staggering moves in bitcoin and somehow feel that they missed the bus, they were reminded last week when the cryptocurrency dropped back almost 35% ...
Read Full Story »

Array BioPharma Slides on Secondary Offering

Posted: September 14, 2017 at 9:15 am

Array BioPharma Inc. (NASDAQ: ARRY) saw its shares turn negative early on Thursday after the firm announced a secondary offering. The company offered no pricing details, but it does value ...
Read Full Story »

Top Analyst Upgrades and Downgrades: GrubHub, Kroger, Newell Brands, Seagate, Snap, Sony, WEX, FireEye and More

Posted: September 11, 2017 at 9:05 am

Stocks were indicated to open sharply higher on Monday, with Hurricane Irma having drifted westward in Florida just enough to cause far less financial damage than what had been expected on Thursday and ...
Read Full Story »

Array BioPharma’s New FDA Submissions Enough to Excite Investors?

Posted: July 5, 2017 at 9:50 am

Array BioPharma Inc. (NASDAQ: ARRY) saw its shares were up handily in Wednesday's premarket after the firm announced a critical submission to the U.S. Food and Drug Administration (FDA). Specifically, ...
Read Full Story »

JPMorgan’s Favorite Biotechs to Buy With Massive Upside Potential

Posted: May 19, 2017 at 8:25 am

After a couple of down years in which the shrill political rhetoric over drug prices kept a pall over the industry, the biotechs are showing some signs of life. In ...
Read Full Story »
approve disapprove

Top Analyst Upgrades and Downgrades: Alcoa, Altria, Ford, GoPro, NVIDIA, International Paper, Transocean and Many More

Posted: February 3, 2017 at 9:15 am

Stocks have seen big swings in a mixed week. There was a dovish Fed meeting that gave no directional bias on rates, and now we have a much stronger than ...
Read Full Story »
thumbs up and down

Top Analyst Upgrades and Downgrades: Amex, Barclays, DuPont, NetApp, Plains All American, Viacom, Disney and More

Posted: January 30, 2017 at 9:15 am

Stocks broke through the DJIA 20,000 and S&P 2,300 barriers last week, but stocks were indicated lower on Monday. Even with this bull market almost eight years old, investors still want ...
Read Full Story »
cash

7 Analyst Stocks Under $10 for Massive Upside Projections

Posted: November 6, 2016 at 10:15 am

The week of November 4 was dominated by investors selling stocks. Despite high valuations, a Federal Reserve that wants to raise interest rates, election uncertainty and even declining earnings, the ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Agrium, Array BioPharma, Encana, GoPro, 3D Systems and More

Posted: November 4, 2016 at 8:50 am

Stocks were looking for direction ahead of the unemployment and payrolls report, but this is after eight days of consecutive selling. For more than five years investors have used a different ...
Read Full Story »
Female patient on gurney

Top 6 Biopharma Gainers of the Past Week

Posted: October 2, 2016 at 10:05 am

Over the past week, a few biotech companies made absolutely massive runs. The health care sector has been under fire from Washington over the past year, but it seems that ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: CBOE, Comcast, GW Pharma, Hormel, Vonage, Wells Fargo and Many More

Posted: September 27, 2016 at 8:45 am

Stocks were indicated higher on Tuesday after Monday's first presidential debate. Despite a bull market that is seven and a half years old, and despite high valuations, investors are still willing ...
Read Full Story »
analysis

4 Biopharma Companies Moving on Monday Ahead of the Presidential Debate

Posted: September 26, 2016 at 10:15 am

Monday is kicking off a very important week in the markets, with earnings season on the horizon and the first presidential debate later in the evening. Biotech and pharmaceutical companies ...
Read Full Story »